BGI Genomics Co., Ltd. (300676.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap18.88B
Enterprise Value16.38B
P/E Ratio-29.42
PEG Ratio-0.6
Price/Sales Ratio4.39
Price/Book Ratio1.99
Enterprise/Revenue3.85
Enterprise/EBITDA-155.58

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.15
Operating Margin-0.14
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.07

Income Statement

Revenue3.7B
Revenue/Share9.23
Gross Profit1.2B
EBITDA6.56M
Net Income-616.66M
Diluted EPS-1.48

Balance Sheet

Total Cash3.16B
Total Cash/Share7.56
Total Debt615.24M
Total Debt/Equity0.07
Current Ratio2.81
Book Value Per Share20.63

Price History

52-Week Change-14.94
52-Week High65
52-Week Low32.55
Moving Average 50 Days41.04
Moving Average 200 Days41.42

Statistics

Average Volume11.47M
Shares Outstanding418.32M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split FactorN/A
Last Split DateN/A
AD